Mr. Ault founded Alzamend Neuro, Inc., a biotechnology firm dedicated to finding the treatment, prevention and cure for Alzheimer’s Disease on February 25, 2016 and has served as its Chairman ever since.
Mr. Ault is a seasoned business professional and entrepreneur who has spent more than twenty-seven years identifying value in various financial markets including equities, fixed income, commodities, and real estate. On March 16, 2017, Mr. Ault was appointed Executive Chairman of the Board for DPW Holdings, Inc. (“DPW”), formerly known as Digital Power Corporation and on December 28, 2017, Mr. Ault was appointed Chief Executive Officer for DPW. Mr. Ault has served as Chairman of Ault & Company, a holding company since December 2015, and as Chairman of Avalanche International Corp since September 2014, a publicly traded company. Since January 2011, Mr. Ault has been the Vice President of Business Development for MCKEA Holdings, LLC, a family office. Through this latter position, Mr. Ault has consulted for a few publicly traded and privately held companies, providing each of them the benefit of his diversified experience, that range from development stage to seasoned businesses.
Mr. Ault became majority shareholder of Franklin Capital Corp and was elected to its board of directors in July 2004 and became its Chairman and Chief Executive Officer in October 2004 serving until January 2006, and again from July 2006 to January 2007. In April 2005, the company changed its name to Patient Safety Technologies, Inc. (OTCBB: PSTX, OTCQB: PSTX) (“PST”) and purchased SurgiCount Medical, Inc. Stryker Corporation (NYSE: SYK) acquired PST at the beginning of 2014 in a deal valued at approximately one hundred twenty million dollars ($120,000,000). PST’s wholly owned operating subsidiary, SurgiCount Medical, Inc., is the company that developed the SafetySponge® System; a bar coding technology for inventory control that aims to detect and prevent the incidence of foreign objects left in the body after surgery.
Mr. Horne has served as the Chief Financial Officer and director for Alzamend Neuro since June 01, 2016. Mr. Horne is a member of the board of directors of DPW Holdings, Inc. (NYSE: DPW) since October 2016. On January 25, 2018, Mr. Horne was appointed as DPW Holdings Chief Financial Officer. Mr. Horne is a director of and Chief Financial Officer to Avalanche International, Corp., a publicly traded company. He has served as the Chief Financial Officer of Targeted Medical Pharma, Inc. (OTCBB: TRGM) since August 2013.
Mr. Horne previously held the position of Chief Financial Officer in various companies in the healthcare and high-tech field, including OptimisCorp, from January 2008 to May 2013, a privately held, diversified healthcare technology company located in Los Angeles, California.
Mr. Horne served as the Chief Financial Officer of Patient Safety Technologies, Inc. (OTCBB: PSTX), a medical device company located in Irvine, California, from June 2005 to October 2008 and as the interim Chief Executive Officer from January 2007 to April 2008. In his dual role at Patient Safety Technologies, Mr. Horne was directly responsible for structuring the divestiture of non-core assets, capital financings and debt restructuring.
Mr. Horne has also held supervisory positions at Price Waterhouse, LLP and has a Bachelor of Arts Magna Cum Laude in Accounting from Seattle University.
Mr. Mansour has been leading the efforts to establish the Company, Board of Directors, hire and contract with all appropriate FDA consulting firms, as well as establish and negotiate all relationships with the scientific and academic community.
Mr. Mansour has been actively involved with disruptive technology as an inventor, manager, executive and coach for more than 3 decades. During that period, he has led innovation and inspired collaboration among facilities in seven states and four continents. He is a master of operations, organizational change management and integrations. Having been involved in more than a two dozen mergers, acquisitions and liquidations, Mr. Mansour has experienced and overseen all sides of the M&A process first hand. His executive positions include CEO, CTO, President, Senior VP of Research and Development, Executive VP of Corporate Development, and VP of Strategic Initiatives. Through his consulting organization, PMC Solutions, since 2008, he has facilitated organizations, entrepreneurs, and disruptive technologies and business models in the sectors of, Bio-Technology, Consumer Electronics, Computer Science, Energy, Health Sciences, Hospitality, and Publishing. Mr. Mansour is currently CEO and Director of MTIX International, Inc. (OTC: AVLP) and Chairman of MTIX, Ltd.